Loading...

Laboratorios Farmaceuticos Rovi, S.A.

0ILL.L•LSE
Healthcare
Medical - Pharmaceuticals
£57.95
£1.04(1.82%)

Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) Stock Overview

Explore Laboratorios Farmaceuticos Rovi, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 76.9/100

Key Financials

Market Cap3B
P/E Ratio22.70
EPS (TTM)$3.32
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Week$56.96
1 Month$49.71
3 Months$40.33
1 Year Target$87.92

0ILL.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $87.92.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.70 and a market capitalization of 3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.70%
5-Day Change
-5.79%
1-Month Change
-9.75%
3-Month Change
-24.14%
6-Month Change
-34.90%
Year-to-Date (YTD) Change
-24.73%
1-Year Change
-41.30%
3-Year Change
-29.13%
5-Year Change
80.78%
All-Time (Max) Change
839.34%

Contact Information

https://www.rovi.es
34 91 021 30 00
Calle José Isbert, 2, Madrid, 28223

Company Facts

2,197 Employees
IPO DateFeb 24, 2011
CountryES
Actively Trading

Frequently Asked Questions

;